Investment
Healthcare
Pharmaceuticals
Unitedstates
Private
Lifesciences
Acquisition
Specializing
M&A Advisory
Lazard
Full Credential Description
Gurnet Point Capital. United States. Announced Date 06/06/2023. Closed Date 21/09/2023. Deal value: $462m. Paratek Pharmaceuticals to be acquired by Gurnet Point Capital and Novo Holdings. Industry: Gurnet Point Capital is a private investment firm specializing in the healthcare and life sciences sectors.